D02.0 ICD 10 Code is a billable and specific code that can be used to indicate a diagnosis of Carcinoma in situ of larynx for reimbursement purposes. The 2023 edition of the American ICD-10-CM code became effective on October 1, 2022.
Type 1 excludes for D02.0 ICD 10 code
- carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (D00.08)
- carcinoma in situ of hypopharyngeal aspect (D00.08)
- carcinoma in situ of marginal zone (D00.08)
Possible back-references that may be applicable or related to D02.0 ICD10 Code:
- C00-D49 Neoplasms
- D00-D09 In situ neoplasms
- D02 Carcinoma in situ of middle ear and respiratory system
Present On Admission (POA Exempt)
D02.0 ICD 10 code is considered exempt from POA reporting
Clinical information about D02.0 ICD 10 code
Throat cancer is a type of head and neck cancer. Throat cancer has different names, depending on which part of the throat is affected. The different parts of your throat are called the oropharynx, the hypopharynx, the nasopharynx, and the larynx, or voice box.
The main risk factors for throat cancer are tobacco use and heavy drinking. Certain types of throat cancer also have other risk factors. For example, having HPV is a risk factor for oropharyngeal cancer.
Symptoms of throat cancer may include:
- A sore throat that does not go away
- A lump in the neck
- Pain or ringing in the ears
- Trouble swallowing
- Ear pain
To diagnose throat cancers, doctors may do a physical exam and history, imaging tests, and a biopsy. You may also need other tests, depending on the type of cancer. Treatments include surgery, radiation therapy, and chemotherapy. Treatment for some types of throat cancer may also include targeted therapy. Targeted therapy uses drugs or other substances that attack specific cancer cells with less harm to normal cells.
NIH: National Cancer Institute
The information in this box was provided by MedlinePlus.gov